BACKGROUND: Extract of piper auritum plays a protective role in streptozotocin-induced diabetic rats, and the mechanism is associated with anti-oxidative damage. However, whether it can alleviate acute spinal cord injury by anti-oxidative stress is unknown.
OBJECTIVE: To investigate the effects of extract of piper auritum on oxidative stress, inflammation and nerve injury of acute spinal cord injury rats.
METHODS: One hundred rats (provided by Chengdu Dashuo Experimental Animal Company) were randomly divided into sham group, spinal cord injury group, and low-, moderate-, and high-dose extract of piper auritum groups. Except for sham group, the rats in the other groups were used to establish acute spinal cord injury model by Allen’s method. Afterwards, the rats in the extract of piper auritum groups were given 100, 200 and 400 mg/(kg•d) extract of piper auritum via gavage, respectively, for 28 consecutive days. Basso, Beattie Bresnahan scores and tilt board experiment were carried out at 3, 7, 14 and 28 days after administration. The concentrations of superoxide dismutase, glutathione peroxidase, malondialdehyde, interleukin-1β, interleukin-6 and tumor necrosis factor-α in serum were measured by ELISA. The protein levels of Bcl-2, Bax, Caspase-3, brain-derived neurotrophic factor, neuronal/glial cell antigen, IκBα, p-IκBα and NF-κB p65 were detected by western blot assay. Spinal cord tissues underwent hematoxylin-eosin staining and TUNEL staining. The study was approved by the Laboratory Animal Ethics Committee of Institute of Tropical Agriculture and Forestry, Hainan University, approval No. NR001803.
RESULTS AND CONCLUSION: (1) Compared with the sham group, the Basso, Beattie Bresnahan scores and the maximal title angle in tilt board experiment in the spinal cord injury group were significantly decreased at different time points after administration (P < 0.01). Compared with the spinal cord injury group, the Basso, Beattie Bresnahan scores and the maximal title angle in tilt board experiment in the moderate- and high-dose extract of piper auritum groups were significantly at 7, 14 and 28 days after administration (P < 0.05, P < 0.01). (2) Compared with the sham group, the spinal cord injury was more serious in the spinal cord injury group, the apoptosis rate, the levels of Bax, Caspase-3, malondialdehyde, interleukin-1β, interleukin-6 and tumor necrosis factor-α, p-IκBα, NF-κB p65, brain-derived neurotrophic factor, and neuronal/glial cell antigen were significantly increased (P < 0.05, P < 0.01), and the levels of Bcl-2, IκBα, superoxide dismutase, and glutathione peroxidase were significantly decreased (P < 0.05, P < 0.01). Compared with the spinal cord injury group, the degree of spinal cord injury in each extract of piper auritum group was alleviated, the apoptosis rate, the levels of Bax, Caspase-3, malondialdehyde, interleukin-1β, interleukin-6 and tumor necrosis factor-α, p-IκBα, NF-κB p65, brain-derived neurotrophic factor, and neuronal/glial cell antigen were significantly decreased (P < 0.05, P < 0.01), and the levels of Bcl-2, IκBα, superoxide dismutase, and glutathione peroxidase were significantly increased (P < 0.05, P < 0.01). (3) These findings imply that extract of piper auritum can attenuate acute spinal cord injury by inhibiting inflammation and oxidative stress and also plays a neuroprotective role in spinal cord injury, and the mechanism may be related to inhibit the activation of NF-κB signaling pathway.